Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Survival From Revision Surgery for New Rigicon® Infla10® Three-piece Inflatable Penile Prosthesis Is Comparable to Preceding Devices


In its first 2 – 3 years of availability, analysis of the first 535 patients implanted with the Rigicon® Infla10® shows safety data for survival from mechanical failure, device infection, other medical problems, and patient dissatisfaction to be consistent with results for established competitor devices. Key findings are very similar to the statistics from initial study and indicate excellent Infla10® freedom from need of revision. Rigicon® Infla10® exhibits comparable device durability.

RONKONKOMA, N.Y., Sept. 2, 2023 /PRNewswire-PRWeb/ — Rigicon is pleased to present a newly published clinical study article titled “Survival From Revision Surgery for New Rigicon Infla10® Three-piece Inflatable Penile Prosthesis Is Comparable to Preceding Devices.”

In its first 2 – 3 years of availability, The Rigicon Infla10® Inflatable Penile Prosthesis shows freedom from revision comparable to existing enhanced devices that have been on the market for decades. Analysis of the first 535 patients implanted with the Rigicon Infla10® (between January 2019 and August 2022) shows safety data for survival from mechanical failure, device infection, other medical problems, and patient dissatisfaction to be consistent with results for established competitor devices.

Key findings are very similar to the statistics from initial study and indicate excellent Infla10® freedom from need of revision. Rigicon Infla10® exhibits comparable device durability.

Mechanical failure: The Rigicon Infla10® mechanical failure rate is acceptable when compared to other three-piece penile prostheses available in market. These results indicate Rigicon Infla10® IPP is safe in terms of mechanical durability.

Infection Incidence: In this study, Rigicon Infla10’s infection rate is found to be very low, with only a single instance among the 535 patients under observation. The infection rate of the Infla10® three-piece IPP with 103 different implanting surgeons is well within expectations.

Further details can be explored at:

https://www.goldjournal.net/article/S0090-4295(23)00641-6/fulltext

Dr. Steven K. Wilson, a respected urologist and contributor to the study, emphasized the implications of these findings, noting, “The Rigicon Infla10® marks a notable advancement in the field of prosthetic urology. The data reaffirms the company’s dedication to providing innovative solutions that genuinely improve the lives of patients.”

Rigicon remains committed to excellence and innovation in prosthetic urology surgery, solidifying its reputation as a reliable provider of delivering solutions that positively impact patients’ lives worldwide.

About Rigicon:
Rigicon is a renowned research, development, and manufacturing entity specializing in prosthetic urology solutions. With over three decades of experience in Prosthetic Urology, Rigicon has emerged as a global frontrunner, with its innovative products available across more than 50 countries. The company prioritizes cutting-edge treatments for various urological conditions, including erectile dysfunction and urinary incontinence. For a comprehensive catalog of products, please visit Rigicon’s official website at www.rigicon.com

Media Contact
Jessica Miranda, Rigicon, Inc., +1 88820290, [email protected],
www.rigicon.com
SOURCE Rigicon, Inc.

Media Contact

Jessica Miranda, Rigicon, Inc., 1 88820290, [email protected], www.rigicon.com

Twitter, LinkedIn

SOURCE Rigicon, Inc.



RAMPART IC Announces the Addition of Rob Williamson to Its Board of Managers


Interventional cardiologists spend extended time in catheterization labs. Their occupation is exposed to the highest levels of radiation in the world.1 These physicians often face debilitating injuries resulting from the 20-30-pound lead aprons traditionally worn to reduce radiation exposure,2 with nearly half reporting some form of orthopedic injury.3 The Rampart M1128, which is designed for procedures conducted by interventional cardiologists, electrophysiologists, interventional neurologists, and interventional radiologists, is a fully adjustable and portable system equipped with transparent radiation-attenuating panels that have 1mm lead equivalency, creating a wide shielding area, protecting the physician and surrounding medical personnel. The powered device can easily be configured and adjusted to allow for subtle positioning to suit type of procedure and the body shape of the patient.

The Rampart system is used by several prominent US healthcare systems and prestigious university medical institutions. In addition, Rampart has signed agreements with distributors in the Middle East, Asia Pacific, Europe, and North America providing its radiation shielding solution to serve healthcare professionals in countries around the world.

“I am pleased to join the Board of Managers at Rampart,” said Williamson. “Like many of the companies I have been involved with, Rampart has a unique value proposition that is specifically focused on an underserved population within our space. After 25 years in and around interventional labs, I have seen firsthand the impact that both radiation exposure and wearing lead can have on the body. Our healthcare providers deserve better, and Rampart is delivering. I’m honored to serve a company with such an important mission.”

Founded in 2018, Rampart is a leading innovator of radiation attenuating medical devices for physicians and staff who perform interventional procedures using fluoroscopic and other medical imaging equipment. Designed to protect the entire team during procedures, Rampart’s products allow teams to operate without having to wear heavy lead aprons and other garments that have been known to cause debilitating musculoskeletal and orthopedic issues for operators. The company’s flagship product, the M1128, is used in cath labs worldwide.

Learn more at rampartic.com

  1. Zakeri F, Hirobe T, Akbari K. Biological effects of the low–dose radiation exposure on interventional cardiologist. International atomic energy agency: Occ Med ( Lond) 2010;60(6): 464-9
  2. Orme NM, Rihal CS, Gulati R, et al. Occupational health hazards of working in the interventional laboratory: a multisite case control study of physicians and allied staff. J Am Coll Cardiol 2015; 65: 820-6.
  3. Klein LW, Tra Y, Garratt KN, et al. Society for Cardiovascular Angiography and Interventions. Occupational health hazards of interventional cardiologists in the current decade: Results of the 2014 SCAI membership survey. Catheter Cardiovasc Interv. 2015 Nov; 86(5):913-24.

“The Rampart team is excited and honored to have Rob join our Board of Managers and leadership team,” said Rampart President and CEO Tom Livingston. “Rob brings a wealth of commercial experience and business leadership skills that will be tremendous in supporting Rampart’s growth.”

Media Contact

Michael Jones, Rampart IC, 1 205-706-2586, [email protected]

SOURCE Rampart IC

Evogen Nutrition Expands Flagship Protein Powder with IsoJect Clear


The visionary mind of 22x Olympia-winning coach Hany Rambod is constantly working to bring something new to the industry that can help elite athletes and gym-goers achieve the results they’re looking for and help build a physique they can be proud of. Evogen Nutrition IsoJect Clear is the “clear” winner in the category for supporting recovery and protein synthesis. This pure whey protein isolate combines purity, taste, and functionality in a single package.

IsoJect Clear redefines whey isolate purity standards with a single-source ultra-pure whey protein isolate that utilizes an all-new clear technology developed by Rambod, setting it apart from other isolates. Through an ultra-triple cold-filtered process, this whey isolate maintains unparalleled bioavailability to help you maximize recovery.

Gone are the days of foamy shakes. IsoJect Clear revolutionizes the shake experience by ensuring a refreshing, clear shake without the lasting foam issue. Available in vibrant, mouth-watering fruit flavors, IsoJect Clear Watermelon and IsoJect Clear Wildberry Blast, add a splash of natural color to your shake, free from artificial colors or dyes.

Your body demands top-tier protein for peak results and efficient recovery following intense training sessions. Evogen Nutrition’s IsoJect Clear harnesses the power of ultra-pure whey protein isolate, enriched with optimal levels of leucine and amino acids (BCAA/EAA) for maximum mTor stimulation and protein synthesis.

IsoJect Clear epitomizes quality by delivering only what your body needs. Fillers and unnecessary ingredients have no place in this formula. This pure whey protein isolate boasts up to 19% fewer calories than your standard whey protein isolate product per serving. Being lower in calories becomes a crucial tool for those engaged in a caloric deficit focused on weight loss while also helping maintain and nourish lean muscle tissue.

Evogen Nutrition’s IsoJect Clear symbolizes the brand’s commitment to empowering athletes, ensuring proper recovery, and reaching new heights in performance.

Evogen Nutrition’s IsoJect Clear is available at www.EvogenNutrition.com and Evogen Elite retail partners across the globe. Discover the future and clear difference in whey isolate protein with IsoJect Clear. Get yours today!

About Evogen Nutrition

Evogen Nutrition, headquartered in Irving, Texas, is a rapidly expanding, healthy lifestyle sports nutrition company that designs and creates a cutting-edge line of nutritional supplements. Founded and led by world-class trainer Hany Rambod, Evogen Nutrition’s elite products appeal to all categories of an active lifestyle, including muscle building, weight loss, and general fitness through a daily nutritional supplement regimen. The foundation of Evogen Nutrition’s nutritional protocols is based on the world-famous FST-7 physique training system invented by Rambod. Evogen Nutrition is sold in over 75 countries worldwide.

For more information, please visit http://www.EvogenNutrition.com

Media Contact

Andrew Dixon, Evogen Nutrition, 1 323-351-9505, [email protected], https://www.evogennutrition.com/

SOURCE Evogen Nutrition